Summary The RB1 gene mutation was investigated in a child with ectopic intracranial retinoblastoma using DNA obtained from both the pineal and retinal tumours of the patient. A nonsense mutation in exon 17 (codon 556) of the RB1 gene was found to be present homozygously in both the retinal and the pineal tumours. The same mutation was present heterozygously in the DNA from the constitutional cells of the patient, proving it to be of germline origin. The initial mutation was shown to have occurred in the paternally derived RB1 allele. The mutation is in an area of the gene that encodes the protein-binding region known as the 'pocket' region and has been detected in other cases of retinoblastoma.
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Keywords: RB1 gene mutation; trilateral retinoblastoma; ectopic intracranial retinoblastoma; polymerase chain reaction-single strand conformation polymorphism Among the tumours developed by patients with retinoblastoma (Rb) are intracranial neoplasms that have an identical histopathological appearance to Rb. The existence of these 'ectopic retinoblastomas' was first recognized by Jacobiec et al in 1977. In 1980, Bader et al suggested the term 'trilateral retinoblastoma' to describe the clinical syndrome of bilateral Rb with an ectopic midline intracranial tumour. They subsequently reported 11 children with characteristics of trilateral Rb (Bader et al, 1982) and suggested that the development of an ectopic midline neuroblastic tumour in a patient with bilateral Rb represents an additional focus of multicentric Rb rather than a second primary tumour and drew attention to the fact that the mammalian pineal gland has a phylogenetic and ontogenetic relationship with photoreception . It was postulated that the mutant Rb gene predisposes individuals to the development of neuroblastic tumours that could arise in any cell of photoreceptor origin. It has been proposed that ectopic Rb might arise mostly in the infant's pineal but also more rarely elsewhere in the diencephalon from germinal matrix cells near those that normally give rise to the optic cup (Bullitt and Crain, 1981) . The comparatively small number of such cells in the pineal and their even smaller numbers in the parasellar tissues would account for the relative scarcity of ectopic Rbs even in genetically susceptible individuals (Zimmerman, 1985) . In 1985, Kingston et al reported 12 ectopic intracranial Rb from 630 children seen at St Bartholomew's and Moorfields Eye Hospitals during a period of 30 years. Among 432 children with bilateral Rb, the prevalence of trilateral Rb was 2.3%, which was thought to be an underestimate, and a figure of 4% was suggested as more realistic. Later reports by De Potter et al (1994) and Amoaku et al (1996) agreed with this figure. In the Dutch population (in the period 1970-94), Moll et al (1996) found the cumulative incidence of pineoblastoma to be 9.3% at the age of 5 years.
With the cloning of the RB1 gene in 1986 (Friend et al, 1986) , genetic screening and identification of causative mutations became possible. Over the years, many RB1 mutations have been identified by several groups using various techniques Yandell et al, 1989; Hogg et al, 1992; 1993; Onadim et al, 1992a; 1993; Blanquet et al, 1995; Lohmann et al, 1996) . These mutations were identified mainly in the constitutional or retinoblastoma tumour tissue of Rb patients. There is only one previous report of an RB1 mutation identified in the second tumour of an Rb patient (Weir-Thompson et al, 1991) and, to the best of our knowledge, no reports involving a pineoblastoma. In this report, we describe the molecular RB1 gene analysis that was carried out on the tissues obtained from a patient with ectopic intracranial Rb seen at St Bartholomew's Hospital. As such, it constitutes the first report on the actual RB1 mutation involved in a case of trilateral Rb.
CASE REPORT
A 13-month-old female infant presented in August 1992 with a 5-month history of an irregular left iris with subsequent onset of clouding of the left pupil. There was no family history of eye cancer or other malignancy.
On examination, she had evidence of left leucocoria and objected to having her right eye covered. Her left eye was glaucomatous with rubeosis iridis. Examination under anaesthetic revealed that the left eye was full of tumour and the right eye contained five tumours. Computerized tomographic (CT) scan of the head and orbits showed enhancing, calcified masses in both globes but no intracranial lesion. In particular, the pineal region was normal. Her left eye was enucleated and histological examination confirmed a well-differentiated retinoblastoma with a predominantly endophytic growth pattern. The tumour had Thereafter, the tumours remained inert and she remained well until May 1995, when she presented with a 4-month history of intermittent headaches. Examination at that time revealed a swollen right disc and a spastic paraparesis. A CT head scan revealed triventricular hydrocephalus with a large calcified mass in the pineal region (Figure 1) .
Surgery was undertaken with partial resection of the pineal mass and insertion of a Pudenz Shulte ventriculo-peritoneal shunt. A subsequent myelogram after surgery showed total occlusion at the upper border of L2 with multiple metastases throughout the cervical and dorsal spine. Retinoblastoma cells were found in her cerebrospinal fluid (CSF). Tumour material was sent for both histological examination and DNA analysis. Histological examination revealed a small round cell tumour indistinguishable from retinoblastoma. The results of the DNA analysis are detailed below.
MATERIAL AND METHODS DNA was prepared from whole blood and tumour tissues using standard phenol-chloroform extraction and ethanol precipitation (Sambrook et al, 1989) . The tumour DNA was screened by PCR-SSCP (polymerase chain reaction-single strand conformation polymorphism) and the mutation detected was identified by sequencing. The general details of PCR-SSCP and sequencing procedures have been described elsewhere (Hogg et al, 1992; Onadim et al, 1993) . The specific details and differences are briefly summarized below.
DNA was amplified in GeneAmp PCR System 9600 (Perkin Elmer). Primers for PCR were synthesized on a phophoramidite column (ICRF, Central Services Division). The PCR reaction ) and the RBi.2 (Toguchida et al, 1993) polymorphisms of the RB1 gene were used. The PCR primers and the procedures for the RB1.20 analysis were as described previously (Onadim et al, 1992b) . The procedure for the detection of the RBi.2 polymorphism was essentially the same as the RB 1.20, except that the primers published in Toguchida et al (1993) were used. RESULTS DNA extracted from the pineal tumour of the patient was screened for the RB1 mutation using PCR-SSCP together with DNAs from other Rb patients and controls. The SSCP gel of exon 17 exhibited an abnormal banding pattern of the pineoblastoma DNA compared with the other samples (Figure 2A ). Sequencing revealed a homozygous C-*T mutation in codon 556 (base 78250) of the RB1 gene ( Figure 2B ). This substitution converts an arginine codon (CGA) to a stop codon (TGA) and as such occurs at a CpG dinucleotide. The mutation also destroys a TaqI and a Hinflll site. When blood DNA of the patient was sequenced, the same mutation was present heterozygously (Figure 2B ), as expected, demonstrating that this is a germline mutation. The DNA from the Rb tumour of the patient also exhibited the mutation homozygously ( Figure 2B ). The mutation was absent in the blood DNA from both the mother and the father of the patient (data not shown).
LOH analysis was carried out using the RB 1.20 and RBi.2 polymorphisms of RB 1. The Rbi.2 was not informative but LOH in both tumours was demonstrated with the RB1.20 (Figure 3) . The RB 1.20 genotype of the patient is 1,4, having inherited allele number 1 from her father and allele number 4 from her mother. As shown in Figure 3 , in both the pineal and the eye tumour, allele number 4 was lost and allele 1 was retained indicating that the initial mutation occurred in the paternally derived RB1 allele.
DISCUSSION
The RB 1 mutation identified in this patient is a nonsense mutation in exon 17 of the gene that codes for part of the 'pocket' region of the Rb protein. The mutation was absent in the blood DNA from both the father and the mother, indicating that it represents a new germline mutation (although we can not exclude the possibility of mosaicism). The mutation was shown to have occurred on the copy of the RB 1 gene derived from the father. This conforms with the fact that new germline mutations in the RB1 gene Zhu et al, 1989; Kato et al, 1994) and in other loci (Vogel and Rathenberg, 1975) are generally found on the paternally derived copy. The mean age at diagnosis for new germline carriers of the RB1 mutation is 14 months (Draper et al, 1992) and Rb in this patient was diagnosed when she was 13 months old. The patient presented with the pineal tumour 32 months after the initial diagnosis of Rb, which fits with the median interval of 34 months reported by Kingston et al (1985) .
The RB1 mutation identified is a C-iT transition occurring within a CpG dinucleotide. High mutability of the CpG sites has been reported for the RB1 gene Cowell et al, 1994) and for other genes (Cooper and Youssoufian, 1988; Cooper and Krawczak, 1990) . The mechanism involved is thought to be spontaneous hydrolytic deamination of 5-methylcytosine to thymine, although local motifs, for example nearby repeat sequences, may also play a role Onadim 1993) . In this case, misalignment with the 'TGAA' sequence 3 bp downstream of the mutated 'CGAA' might have resulted in the C-*T substitution.
Recent reports of CpG methylation at the sites of recurrent mutations in the NFl and the BRCA1 genes (Andrews et al, 1996; Rodenhiser et al, 1996) , however, support a deamination cause. This mutation was first reported by Hogg et al (1993) as the somatic mutation in the retinal tumour from a unilateral non-hereditary Rb case. Subsequently, in the only two other reports of the same mutation, it was identified as a germline mutation (Cowell et al, 1994; Liu et al, 1995) . It seems, therefore, that although this patient has developed an ectopic Rb and as such is different from the other 'ordinary' Rb cases, the RB1 mutation she carries constitutes part of the spectrum of RB1 mutations seen in other Rb phenotypes, including non-hereditary ones. To date, only families exhibiting a 'mild phenotype' and lower penetrance of the RB1 mutation have been shown to carry mutations that are different -missense and promoter region mutations or in-frame deletions that may not totally abolish the function of the protein (Sakai et al, 1991; Onadim et al, 1992a; Dryja et al, 1993; Lohmann et al, 1994; Cowell et al, 1996) .
There are limited previously published data on abnormalities in pineoblastomas in the literature. Among these are structural abnormalities of chromosome 1 (Griffin et al, 1988 ), 11 (Sreekantaiah et al, 1989 and 17q (Kees et al, 1994) . A tumour-related locus on 17 p13 -distinct from p53 -was also reported for some paediatric neuroectodermal tumours (Biegel et al, 1992) . We have examined the status of the p53 gene in this pineoblastoma by performing LOH analysis (using the p53 intron 1 VNTR - Hahn et al, 1995) and by sequencing the four highly conserved regions reported to British Journal of Cancer (1997) 76(11), 1405-1409 contain the majority of mutations in human tumours (exons 5-8: codons 117-286, Hollstein et al, 1991) . There was no LOH for p53 in either the retinoblastoma or the pineal tumour, and no p53 mutations were detected in the pineal tumour in the conserved regions studied (data not shown). The elucidation of the spectrum of genes involved in the development of pineoblastomas and a better assessment of mutational patterns in trilateral Rb awaits analysis of more of these rare tumours.
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